- Impairment to the US business as a result of the termination of revenues from Homology Medicines Inc.
- Financial performance impacted by the non-recurrence of COVID-19 vaccine bioprocessing volumes
- Reorganisation of its workforce to create a more streamlined structure across the UK and the US
- Rapid technical change in the cell and gene therapy sector
- Reliance on third parties for the supply of raw materials and certain out-sourced services
- Complexity of bioprocessing of viral vectors, with batches potentially failing to meet required specifications
- Cyber-attacks seeking to compromise IT systems and data
- Increased competition for highly skilled employees
- Failure to comply with laws, rules and regulations across the UK, the EU and the US
- Potential product liability risks
Oxford Biomedica plc
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Oxford Biomedica plc disclosed greenhouse gas emissions of 3.6K tCO2e. By scope: Scope 1: 802.83 tCO2e; Scope 2: 1.2K tCO2e; Scope 3: 1.5K tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
3.6K tCO2e
2023
Energy Use
15.6M kWh
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 802.83 tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 1.2K tCO2e |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 1.5K tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 3.6K tCO2e |
| 2022 | 4.5K tCO₂e (location based) |
| 2021 | 4.0K tCO₂e |
| 2020 | 4.1K tCO2e |
| 2014 | 2.3K tonnes of CO2e |
| 2013 | 2.3K tonnes CO2e |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced water flushes when storing liquid waste, drastically reducing volumes sent for waste treatment
- Achieved a second consecutive entry into the International Freezer Challenge
- Implemented lighting upgrades and encouraged carpooling
🎯 Climate & Sustainability Targets
🔜 Short-term
- 10% reduction in Scope 1 and Scope 2 GHG emissions by the beginning of 2027 from 2021 baseline
- 10% of electric energy to be fully renewable by 2027
- Switch to 100% fully electric vehicles used by the Group on site by the end of 2027
📅 Medium-term
- Achieve Operating EBITDA margins in excess of 20% by the end of 2026
- Be profitable on an EBITDA level in 2025
- Three-year revenue CAGR of more than 35% for the years 2023-2026
🔭 Long-term
- Net zero emissions by 2050
🌱 ESG Focus Areas
PeopleInnovationCommunitySupply ChainEnvironmentGovernance, Integrity and Ethics